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One of the most important determinants of dermatological and systemic penetration after topical application is the
delivery or ﬂux of solutes into or through the skin. The maximum dose of solute able to be delivered over a given
period of time and area of application is deﬁned by its maximum ﬂux (Jmax, mol per cm
2 per h) from a given vehicle.
In this work, Jmax values from aqueous solution across human skin were acquired or estimated from experimental
data and correlated with solute physicochemical properties. Whereas epidermal permeability coefﬁcients (kp) are
optimally correlated to solute octanol–water partition coefﬁcient (Kow) and molecular weight (MW) was found to be
the dominant determinant of Jmax for this literature data set: log Jmax¼3.90–0.0190MW (n¼ 87, r2¼ 0.847,
po0.001). Estimated solubility in octanol (Soc) was also a determinant, but improvement in the regression by the
addition of log Soc was small (r
2 increased to 0.856). Addition of other physicochemical parameters to MW by
forward stepwise regression only marginally improved the regression with a melting point (Mpt) term (r2¼ 0.879)
and then hydrogen bonding acceptor capability (Ha) (r
2¼ 0.917) is signiﬁcant. Validation of the equation above was
carried with a number of other data sets: an aqueous vehicle with full- and split-thickness skin (r2¼ 0.784, n¼ 56),
some pure solutes (r2¼ 0.537, n¼ 34), an aqueous vehicle with ionizable solutes (r2¼ 0.282, n¼ 54) and solutes
from a propylene glycol vehicle (r2¼ 0.484, n¼ 36). An analysis of the entire database gave the equation log
Jmax¼4.52–0.0141MW (n¼ 278, r2¼ 0.688, po0.001), with inclusion of Mpt and Ha increasing r2 to 0.760 (n¼ 269).
Separate analysis of full- and split-thickness skin data conﬁrmed that the dermal resistance term had only a
marginal effect on overall Jmax. Application of the latter model to an in vivo situation where the dermal capillary bed
is slightly below the epidermal–dermal junction revealed that the dermal resistance term was unnecessary for
in vivo predictions for most solutes.
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Topical dermatological therapy is widely used to manage
skin diseases. In addition, penetration of solutes through
the skin may occur in environmental exposure or in applying
transdermal delivery systems to treat a variety of local and
systemic disorders. An important determinant of the local,
systemic, or toxicological effects of a topically applied drug
is its possible rate of delivery or flux, i.e., the amount of drug
that can possibly penetrate the skin per unit time. The rate
at which the solute is absorbed after topical exposure is
related to the nature of the substance, its vehicle and the
condition of the skin; the amount absorbed is a product of
the rate of absorption and exposure time (Roberts and
Walters, 1998).
In practice, it is the maximum flux (Jmax) of a solute that is
of most interest in determining the maximal dermal, toxic, or
systemic effect. Almost all studies concerned with predict-
ing skin permeability have focused on skin permeability
coefficients (kp, cm per h) from aqueous solutions (Scheu-
plein, 1967; Scheuplein et al, 1969; Anderson et al, 1988;
Flynn, 1990; Potts and Guy, 1992; Pugh and Hadgraft, 1994;
Abraham et al, 1995; Roberts et al, 1995, 1996, 2002; Pugh
et al, 1996; Ghafourian and Fooladi, 2001; Vecchia and
Bunge, 2002a, b). Further, if the maximal flux for a solute is
known, its flux from any vehicle can be estimated using its
fractional solubility in the vehicle after accounting for
vehicle-induced changes in skin permeability (Roberts et al,
2002). Interestingly, relatively few studies have examined
Jmax-solute structure relationships using human skin data
(Higuchi and Davis, 1970; Higuchi, 1978; Kasting et al, 1987;
Roberts and Sloan, 2000; Roberts et al, 2002). Kasting et al
(1987) reported that log octanol solubility (log Soc) and
molecular volume were significant predictors of log Jmax for
35 compounds from saturated propylene glycol (PG)
solutions through split human skin. Other determinants of
Jmax include solute molecular size (MW), octanol–water
partition coefficient (Kow) and melting point (Mpt) (Roberts
et al, 2002).
In this study, we focused on collecting the published data
available for human skin epidermal penetration with the goal
of defining the relationship between solute Jmax determined
from experimental values and solute physicochemical prop-
Abbreviations: Ha, hydrogen bonding acceptor capability; Jmax,
maximum flux (mol per cm2 h); Kow, octanol/water partition
coefficient; kp, permeability coefficient (cm per h); Mpt, melting
point (Kelvin); MV, molar volume (cm3 per mol); MW, molecular
weight (Daltons); Saq, aqueous solubility (mol per mL); Soc, octanol
solubility (mol per mL)
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erties. We used this data to construct an extensive training
database of maximum fluxes from aqueous solutions for our
regression models and validated the model with experimen-
tal data for full- and split-thickness skin, ionized solutes, pure
solutes, and maximum fluxes from PG. Maximum fluxes from
pure solutes and PG were used as validation only, as they
can affect skin permeability to different extents.
Results and Discussion
Epidermal membranes Stepwise regression of Jmax
against all physicochemical parameters for the training set
identified solute MW as the main predictor (Fig 1A, B),
according to:
log Jmax ¼ 3:90 0:0190MW; p < 0:001;
n ¼ 87; r2 ¼ 0:847 ð1Þ
The experimental temperature dependence, modelled as
MW/T instead of MW term in Equation (1), did not
considerably improve the regression (r2¼0.850). It is likely
that the high inherent variability associated with the many
different skin donors, experimental designs and inter-
laboratory procedures for the solutes within the database
swamped previously reported temperature dependency in
skin transport (Scheuplein, 1967; Roberts et al, 1978). Log
Soc as a predictor alone yielded r
2¼ 0.356. Inclusion of
logSoc with MW, however, slightly improved the prediction
of log Jmax over that for MW alone (r
2¼ 0.847–0.856). The
‘‘free volume’’ model for diffusion of solutes within SC lipids
(Kasting et al, 1987) is one contributor for a dependency of
Jmax on molecular size.
The maximum flux for certain series of solutes with a
similar MW has been reported to be associated with a log
Kow of 2.5–3 and to be greatest for solutes with a low Mpt
(Roberts and Walters, 1998). Stepwise regression analysis
of the training data set with Mpt, log Kow, and (log Kow)
2
(Equation (4)) as well as MW confirmed MW as the main
determinant of log Jmax and showed Mpt a significant
covariate (r2 increasing from 0.847 to 0.877). Other terms in
Equation (1) were not significant. Hydrogen bonding has
also been recognized to be a determinant of permeability
coefficients of solutes from aqueous solutions (Abraham
et al, 1995; Potts and Guy, 1995; Pugh et al, 1996; Roberts
et al, 1996; du Plessis et al, 2002). In stepwise regression
of Equation (5) the main determinant was MW, followed
by the Mp as a covariate and then Ha as a third covariate
(r2¼0.917), with Hd having no significant effect (log
Jmax¼4.35–0.0154MW–0.293Mpþ0.371Ha). Pugh et al
(1996) had suggested that Ha was a more significant
determinant of solute diffusivity in SC lipids than solute
Hd. When Equation (5) was used with a Mpt instead of Mp

the improvement as compared with Mp term decreased
from r2¼0.879 to 0.869 and the additional effect due to Ha
from r2¼0.917 to 0.888. Mpt is a more significant covariate
of Jmax than Soc, possibly reflecting SC lipids having slightly
different properties compared to octanol but consistent with
Mpt being a dominant determinant of solute solubility
(Yalkowsky and Valvani, 1980) in SC lipids. Given that
substantial variability in permeability coefficients between
laboratories has previously been reported (Vecchia and
Bunge, 2002b), the effect of different laboratories as a
determinant of the variability of Jmax was studied. The
inclusion of laboratories (six groups; n  5 solutes; Table
S1), as a parameter, did not significantly improve the
forward stepwise regression for Jmax. In summary, the
parameters which improved the model fit in addition to MW
were the Mp and Ha.
Molar volume (MV) alone, estimated by the Fedors’
group contribution method (Fedors, 1974), was a poorer
predictor (log Jmax¼3.53–0.0264MV, r2¼0.805) than MW
alone (r2¼ 0.847). Inclusion of log Soc with MV yielded an r2
of 0.876, whereas that for the Mp (Equation (5)) with MV
gave an r2 of 0.929 with the addition of Ha by stepwise
regression increasing r2 further to 0.937 (logJmax¼3.89–
0.0180MV–0.342Mpþ0.175Ha). MV combined with Mp
and Ha has a slightly larger r
2 (¼0.934) than the r2 (¼0.917)
for MW combined with Mp and Ha. We suggest that MW
alone is a better predictor than MV due to higher correlation
Figure 1
Relationship between Jmax and MW and Log SOC. (A) Jmax values for
solutes from aqueous solution through human epidermal membranes
(the training set, circles), regression line based on Equation (1) using
MW (solid line) and 95% confidence intervals (dashed lines). Solid
symbols indicate Jmax values obtained using saturated aqueous
solutions. Most significant outliers are marked with arrows and their
number in the table are given. (B) Jmax values for the training set for low
(log Soco3.55, circles) medium (3.55olog Soco2.3, box) and high
(log Soc42.3, triangles) solubility in octanol.
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of molecular weight with Mp and Ha (0.78 and 0.66) than
molecular volume with Mp and Ha (0.62 and 0.43). This
higher correlation of MW with Mp and Ha (which have
significant contribution to Jmax) most likely determines that
MW is a better predictor of Jmax than MV if taken alone, but
MV is a slightly better determinant than MW when Mp and
Ha contributions are already taken into account. Molar
volume estimates by various methods can differ greatly. For
instance, molar volumes of 31.3 cm3 per mol and 59.6 cm3
per mol (ethanol), 48.9 cm3 per mol and 90.4 cm3 per mol
(benzene), 215.8 cm3 per mol and 255.6 cm3 per mol
(hydrocortisone) were obtained with the enhanced Bondi
method (Zhao et al, 2003) and Fedors’ method (Fedors,
1974) respectively. Given the range of methods to estimate
molar volume, the reported inconsistencies and arbitrary
assumptions as well as solvation effects (Kharakoz, 1992;
Lepori and Gianni, 2000), the readily available, simply
calculated and precisely defined MW was used as the
predictor of size in this work.
Given that Kasting et al (1987) had reported Soc was a
greater determinant of Jmax for solutes from saturated PG
through human skin than MW, the dominance of MW in the
regression obtained for the training set in Equation (1) was
unexpected. Figure 1B shows that, after correction for MW,
no consistent pattern is evident between errors in predicting
Jmax with the molecular weight (log[Jmax_predicted/Jmax]) and
log Soc for the training set. The difference in the relative
contribution of log Soc and MW as predictors of log Jmax in
this work and that of Kasting et al (1987) may be related to
solute and vehicle selection. This training set from aqueous
solutions has a wider MW range of 18–477 and log Soc
range of 1.3 to 7.66 compared to the ranges in the data
for PG of Kasting et al (1987) of MW 108–434 and of log Soc
2.02 to 5.47. Another potential reason for the difference
could be that whereas Kasting et al (1987) used measured
values of Soc, calculated values for Soc (Soc¼SaqKow) were
used in our analysis.
Validation using full- and split-thickness skin data
set Figure 2A shows that the Jmax data for aqueous
solutions and full- and split-thickness skin largely falls
within the 95% CI obtained for SC and epidermal
membranes based on MW. Analysis of the goodness of
prediction of the data from Equation (1) yielded an r2 of
0.784 (n¼ 56). Attempts to account for the additional
dermal resistance by regression of full- and split-thickness
skin data with Jmax defined by Equation (7), only improved
marginally overall expression for determination of Jmax
Figure 2
Relationship observed between Jmax and MW for solute groups. Jmax values from aqueous solutions and the full and split skin (A), pure liquids
through human skin (B), ionized solutes from aqueous solutions (C) and from PG vehicles for low (log Soco4.6, circles) medium
(4.6ologSoco3.8, box) and high (log Soc42.3, triangles) solubility in octanol (D). Solid line shows prediction based on Equation (1) using
MW as a predictor and dashed lines show 95% confidence intervals. Solid symbols indicate Jmax values obtained using saturated vehicles. Most
significant outliers are marked with arrows and their number in the table are given.
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(n¼ 56, r2 increasing from 0.784 to 0.785):
log Joverallmax ¼ 3:90 0:019MW
 logð1þ 101:7þ1:0 logKow0:019MW

ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
MW
p
 hÞ; r2 ¼ 0:785
ð2Þ
The substances most affected by the inclusion of the
dermal resistance term were those with a low MW and a
high log Kow (e.g., benzene, pentanol, hexanol, isoquino-
line). The correction to the log Jmax due to the dermal term
does not exceed 0.34 log units for the solutes and is small
compared to the average variability in the data.
For the few compounds that were poorly predicted in
these thicker membranes using Equation (2) there was an
underestimation of log Jmax(predicted), contrary to intui-
tively expected overestimation of calculated Jmax due to the
presence of dermal resistance. One explanation could be a
greater variability in the integrity of full- and split-thickness
skin barrier function compared with epidermal membranes,
as a range of integrity measures are usually applied to the
latter. The Jmax of digitoxin and ouabain were most
noticeably higher than that predicted by Equation (1). One
possible explanation for this marked deviation could be that
Equation (1) only works reliably for MWo500. Another
possibility is that, as argued by Vecchia and Bunge (2002a,
b), permeability coefficients for these two solutes are
suspiciously high and should be excluded from analyses.
Validation using other data Figure 2B shows that most of
the Jmax data for pure solutions lie within the 95% CI
obtained for the regressions based on the training set.
Analysis of the goodness of fit for this data with Equation (1)
yielded an r2¼0.537 (n¼34). Some deviations in Jmax were
expected for pure solutions as a consequence of dehydra-
tion, delipidization, solute depletion, and other direct effects
on the stratum corneum (Roberts et al, 2002). Figure 2C
shows that the majority of the data for the epidermal
transport of aqueous ionized solutions (80%) are again
within the 95% CI obtained for the regressions based on the
training set. An analysis of the goodness of fit for this data
with Equation (1) yielded an r2¼0.282 (n¼ 54).
Figure 2D shows that Jmax for solutes in saturated
solutions of PG (Kasting et al, 1987) also largely super-
impose within the 95% CI predicted by the training set. An
analysis of the goodness of fit of this data with Equation (1)
yielded an r2¼0.484 (n¼36). The apparent slightly higher
mean value for PG relative to the mean for the data in the
training set is consistent with PG being a known enhancer
of percutaneous absorption (Kasting et al, 1993). Also
shown in Fig 2D is the effect of Soc as a determinant of Jmax.
It is evident, as previously shown by Kasting et al (1987),
that the solutes with higher solubility also generally have
higher Jmax.
Regression of complete data set Given that the validation
data sets support the training set regression with Equation
(1), a regression on the total data set was carried using MW
as a predictor:
log Jmax ¼ 4:52 0:0141MW; p < 0:001;
n ¼278; r2 ¼ 0:688 ð3Þ
The result of this regression is shown in Fig 3A. We also
performed the regression on a total database using all the
predictors found significant in a stepwise regression of
the training set (logJmax¼4.50–0.0126MW–0.169Mpþ
0.120Ha, n¼269, r2¼ 0.760). All the parameters were found
to be significant (MW: po0.001, Mp: po0.001, Ha:
p¼0.003) and ranked in importance in the same order as
for the training set (1: MW, 2: Mp, 3: Ha). The result of
regression is shown in Fig 3B. It can be seen, comparing the
dispersion in data in Fig 3A and B, that improvement in the
prediction due to extra parameters is moderate.
Implications of the present analysis The present work
suggests that MW can be used to give an initial estimate for
maximum skin flux for any given solute in a saturated
solution or as a pure solute. Deviations from these
estimates may be anticipated for those solutions or solutes
known to affect skin permeability by one of the number of
Figure3
Prediction of Jmax for total database. (A) Jmax versus MW values for
entire database (circles). Solid line shows prediction based on Equation
(3) using MW as a predictor and dashed lines show 95% confidence
intervals. (B) Jmax_predicted vs. Jmax using MW, Mp
, and Ha. Solid line is
Jmax¼ Jmax_predicted, and dashed lines show 95% confidence intervals
for the regression.
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mechanisms described (Roberts et al, 2002). It is possible
that the extent of deviation may eventually be derived from
emerging enhancer–solvent property relationships. Impor-
tantly, the flux of any solute at a given concentration in a
given formulation may be defined as the product of Jmax
and the fractional solubility in that formulation.
Solute MW has also been reported to be the only
significant determinant of the dermal blood clearance of
solutes (Singh and Roberts, 1996). Application of Equation
(1) to an in vivo situation where the dermal capillary bed is
slightly below the epidermal–dermal junction revealed that
the dermal resistance term was unnecessary for in vivo
predictions. Hence, transdermal delivery into the systemic
circulation is likely to depend on MW irrespective of whether
the rate-limiting step for skin absorption is diffusion through
the stratum corneum or removal by dermal blood supply.
It is to be emphasized that the presented data sets are
for skin penetration studies using excised human skin. As a
consequence, the receptor conditions do not necessarily
represent those in vivo provided by blood as well as the
potential effects of epidermal metabolism, dermal binding
or altered blood flow on epidermal penetration (Hotchkiss,
1998; Roberts and Cross, 1999) have not been considered
in this analysis.
It should be recognized that there are a number of
limitations associated with the predictive relationships
reported in this study. The first lies in the limitation in the
data available in that it does not have as much representa-
tion across the full range of all parameters as would be
desirable for optimal prediction using the regression
equations obtained in this work. For example, while the
log Kow ranges from 5.7 to þ 8.7 in Table S1, only three
compounds have a log Kow44.5 and 8 with a log Kowo2.
There is clearly a need for the generation of additional data
to provide a more representative range in physicochemical
properties with corresponding Jmax values to supplement
that presently available in Table S1. Accordingly, the use of
the present regressions to estimate Jmax using solute
physicochemical properties should be undertaken with
caution. Secondly, whilst MW is the main parameter
predicting Jmax, it is to be emphasized that Mp
 and Ha
are also predictors. The significance of Mp is most evident,
for instance, for solutes with identical MW and Ha and in
which the structures differ in whether one of the aromatic
groups is in the o-, m- or p-position as illustrated by methyl
4-hydroxybenzoate (No. 146, Table S1) and methyl salicy-
late (No. 263, Table S1). The third limitation is the variability
of data arising from studies undertaken in different
laboratories, with different conditions, and on skin samples
from different donors, as well as different anatomical sites.
In that regard, the predicted Jmax values are intended to be
used as a guide only, and given the scatter of existing
experimental data, can be expected to fall within the degree
of accuracy allowable from the variability of the data set used.
Conclusion
A large amount of published data available for skin
epidermal maximum fluxes have been compiled with the
goal of predicting Jmax of solutes through human skin from
the solute physicochemical properties. The database set
contains a diverse set of pharmacological and toxic
compounds with data variability arising from different
inter-laboratory procedures, skin donors, techniques, and
experimental temperatures. The significance of regression
models obtained is therefore, surprisingly high.
MW was found to be the main predictor of Jmax for
human skin. The prediction could only be slightly improved
by inclusion of experimental temperature, Mpt, Mp, log
Soc, and Ha of the solute. This model also predicted the
overall Jmax through full- and split-thickness skin, as well as
other data such as pure solutes, ionized drugs, and Jmax
from saturated PG solutions.
Materials and Methods
Database The Jmax values of solutes and physicochemical and
structural parameters used in this paper are shown in Table S1. The
complete database of 278 records encompassed solutes with an
extremely wide range of physicochemical properties with log Kow
values ranging from 5.7 to 8.7 (3.88 to 4.52), MW varying from
18 to 765 g per mol (46–504g per mol), Mpt from 147 to 582 K
(114 to 293 K) and Saq from 6.9E10 mol per mL to completely
miscible with water (8.0E9 mol per mL to completely miscible) (in
brackets the range is shown without three compounds with
extreme values of the parameter at each end). The database
contained results from studies performed at a range of experi-
mental temperatures from 221C to 391C. Jmax values were
estimated from the product of the reported permeability coefficient
(kp) and aqueous solubility (Saq) (i.e., Jmax¼ kp  Saq). The aqueous
solubility used in the calculation of Jmax was adjusted to the
experimental temperature (Yalkowsky and Valvani, 1980; Pinal and
Yalkowsky, 1988). In some cases Jmax was available directly since
the work had been done using saturated donor solution or authors
reported Jmax. The experimental and estimated physicochemical
properties were also collected using Advanced Chemistry Devel-
opment (ACD, Toronto, Canada) Software Solaris V4.67 (SciFinder
Scholar 2001) and SRC Interactive PhysProp database. Octanol
solubility was calculated as Soc¼SaqKow. Molecular volume (MV)
for solutes was estimated by the Fedors’ (1974) group contribution
method.
The database consisted of five separate data sets: (1) training
set of 87 records, (2) full- and split-thickness skin set of 56 records,
(3) pure liquid vehicle set of 34 records, (4) ionized solutes set of 54
records, and (5) PG vehicle set of 36 records (Kasting et al, 1987).
These sets are designated as (Set¼ ) t, vs, vp, vf, and vk,
respectively, in Table S1. There were also 11 solutes rejected from
the training set due to the lack of experimental data for the values
for Mpt (Set¼ vm) or Saq (Set¼ ve).
The developed training set of 64 different solutes (87 records)
contains transdermal delivery data using aqueous vehicles on
human skin. The inclusion criteria were that the membrane was
stratum corneum (SC) or epidermis, donor and receptor fluids
contained no organic liquid, the penetrant was not applied as pure
liquid to the membrane, ionization was  10% at the reported
donor phase pH, and the experimental value for Mpt, Saq, and
either Jmax or kp was known. Theoretically based estimates of Saq
were deemed unsuitable for the training set as they generally use
predictors such as log Kow and Mpt (Roberts et al, 2002), which are
also potential determinants of Jmax. For those solutes where
experimental values were not available, the estimated values were
taken from SRC Interactive PhysProp database and used only in
one of validation data sets. Jmax values of ionized solutes were
calculated from reported experimental kp values and total
solubilities given in the SRC database (which SRC advises is
mainly total solubility in distilled water). Given that the available
literature suggests both ionized and unionized species contribute
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to observed flux (Swarbrick et al, 1984; Oakley and Swarbrick, 1987;
Hadgraft and Valenta, 2000) and the uncertainty of pH values for the
solutions used in both flux and solubility studies, no adjustments
were made to correct for (1) possible differences in ionization
between solutions used in penetration and in solubility studies or (2)
the potential that unionized solute flux is likely to be greater than that
for an ionized solute at the same solute concentration.
Data analysis Jmax values were related to various physicochem-
ical properties using stepwise multivariate regression analysis of
various variables including the (logKow)
2 term adopted by Hansch
and Leo (1979):
log Jmax ¼ a bMW cMptþ d logKow þ d2ðlogKowÞ2: ð4Þ
Given that the solute’s hydrogen bond acceptor (Ha) and donor (Hd)
capacities could have effect on Jmax, we also examined the
following equation for Jmax (modified from Roberts et al, (2002) with
the dependence on Mpt being described using the Mpt term:
Mp ¼ DSfðMpt TÞuðMpt TÞ=T, from Yalkowsky’s solubility
equation (Yalkowsky and Valvani, 1980; Pinal and Yalkowsky
1988), where DSf is the entropy of fusion of a solute, u(x) is the unit
step function (i.e., u(x)¼ 1 for x40 and u(x)¼ 0 for xo0)):
log Jmax  a bMW cmpMpþ caHa  cdHd þ ck logKow; ð5Þ
where T is the experimental temperature, and a, b, cmp, ca, cd and
ck are regression coefficients.
When the dermis provides a significant resistance in addition to
the epidermis, the Jmax can be expressed in the form of Equation
(6), if it is assumed that the dermis and epidermis are a series of
resistances and the Jmax in each layer is the product of the kp for
that layer and the solubility in the vehicle.
Jmax ¼ JmaxðscÞ 1þ
JmaxðscÞ
JmaxðotherÞ
 1
: ð6Þ
Equation (6) can be further simplified by assuming that the
solubility in the SC is proportional to that in octanol (Soc) (Kasting
et al, 1987), that the solubility in dermis and viable epidermis
(S(other)) is proportional to that in Saq, and the diffusivity in the
dermis and viable epidermis(D(other)) is proportional to the inverse
square root of MW (Bunge and Cleek 1995). Noting also that
Kow¼Soc/Saq, Equation (6) becomes:
log Joverallmax ¼ log Jepimax 1þ
SðscÞ
SðotherÞ
 DðscÞ=hðscÞ
DðotherÞ=hðotherÞ
 1" #
ﬃ a bMW logð1þ 10cþd logKowbMW 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
MW
p
 hÞ;
ð7Þ
where h is the thickness or diffusivity path length in the viable
epidermis and dermis.
SPSS statistical software (SPSS Inc., Chicago, IL) (11.0 for
Windows) was used for linear regression data analysis and
Scientist (MicroMath Scientific Software v. 2.0) was used for non-
linear regression data analysis. The dependent variable in all
regressions was log Jmax.
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